Par Drugs & Chemicals Ltd share price logo

Par Drugs & Chemicals Ltd

NSE: PAR

Small Cap

Pharma Sector

₹140.92

-0.16

(-0.11%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Par Drugs & Chemicals Stock Performance

as on September 11, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹134.03
    ₹147.96
    downward going graph

    4.89%

    Downside

    5.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹78.05
    ₹180.00
    downward going graph

    44.61%

    Downside

    27.73%

    Upside

    downward going graph

Par Drugs & Chemicals share price movements today

Previous Close
₹141.08
Open
₹141.99
Volume
76.30K
Upper Circuit
₹148.13
Lower Circuit
₹134.03
Day's Low - High
₹134.03 - ₹147.96
52 Week Low - High
₹78.05 - ₹180.00

Par Drugs & Chemicals Historical Returns

1 Month Return
+ 36.63 %
3 Month Return
+ 62.57 %
1 Year Return
+ 29.71 %
3 Year Return
-24.28 %
5 Year Return
+ 25.26 %

Par Drugs & Chemicals Fundamentals

as on September 11, 2026 at 4:01 pm IST

Market Cap

₹173.40 Cr

Return on Equity (ROE)

9.95

PE Ratio (TTM)

11.96

Return on capital employed (ROCE)

14.53

Industry PE ratio

51.81

Beta (LTM)

1.14

P/B Ratio

1.06

Dividend Yield

0

PEG Ratio

42.72

Quarterly Earnings Growth YOY

41.44

EPS (TTM)

0

Book Value

0

Par Drugs & Chemicals Stock Valuation

as on September 11, 2026 at 4:01 pm IST

Par Drugs & Chemicals in the last 5 years

  • Overview

  • Trends

Lowest (6.77x)

March 28, 2025

Today (11.96x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (39.61x)

October 11, 2021

LowHigh

Today’s Price to Earnings Ratio: 11.96x

Par Drugs & Chemicals Technical Analysis

Track how Par Drugs & Chemicals technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish11
Bullish1
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
-0.77
Bearish
CCI (20)
-40.51
Neutral
RSI (14)
42.58
Neutral
Momentum (10)
-2.5
Bearish
ADI (14)
40.08
Bearish
Ultimate Oscillator (7,14,28)
36.81
Neutral

Moving Averages

Name

Value

Action

SMA (20)
141.24
Bearish
EMA (20)
141.12
Bearish
VWMA (20)
140.64
Bearish
SMA (50)
142.73
Bearish
EMA (50)
141.83
Bearish
SMA (200)
139.21
Bullish
EMA (200)
140.24
Bearish
KAMA (200)
142.17
Bearish
DEMA (200)
141.71
Bearish

Par Drugs & Chemicals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Par Drugs & Chemicals with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Par Drugs & Chemicals Ltd image
Par Drugs & Chemicals Ltd
NA173.405.05%0.0013103
Advanced Enzyme Technologies Ltd image
Advanced Enzyme Technologies Ltd
BUY3,285.38-5.77%0.53173745
Vista Pharmaceuticals Ltd image
Vista Pharmaceuticals Ltd
NA35.39-7.88%0.00-510
Vaishali Pharma Ltd image
Vaishali Pharma Ltd
NA114.4226.53%0.00699
Dishman Carbogen Amcis Ltd image
Dishman Carbogen Amcis Ltd
NA2,622.20-4.23%0.68972,931
See all

Par Drugs & Chemicals Stock’s Investor Sentiment and Interest

Investment in Par Drugs & Chemicals Ltd Shares on INDmoney has grown by 464.94% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:464.94% versus previous 30 day period

Search interest for Par Drugs & Chemicals Ltd Stock has increased by 281% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:281% versus previous 30 day period

Par Drugs & Chemicals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
25.89
24
22.82
22.61
34.66
21.38
22.33
26.05
28.66
29.34
19.61
31.28
Other Income
0.05
0.23
-0.05
0.07
1.02
0.27
0.79
1.84
0.48
1.33
0.36
0.94
Total Income
25.94
24.23
22.77
22.68
35.67
21.65
23.12
27.88
29.14
30.67
19.97
32.22
Expenses
18.52
18.77
16.73
18.37
23.25
19.95
19.9
22.49
22.59
23.28
18.17
24.9
Operating Profit
7.37
5.23
6.09
4.24
11.41
1.43
2.43
3.56
6.07
6.06
1.44
6.38
Operating Profit Margin %
28.47%
21.79%
26.69%
18.75%
32.92%
6.69%
10.88%
13.67%
21.18%
20.65%
7.34%
20.4%
Profit Before Interest, Tax and Depreciation
7.41
5.46
6.05
4.31
12.42
1.7
3.22
5.4
6.55
7.39
1.8
7.32
Interest
0.03
0.02
0.05
0.02
0.03
0.01
0.02
0.02
0.05
0.01
0.04
0.02
Depreciation
0.85
0.87
0.89
0.9
0.91
0.91
0.92
0.9
0.94
0.93
0.93
0.96
Profit Before Tax
6.53
4.57
5.11
3.39
11.48
0.78
2.28
4.48
5.56
6.45
0.83
6.34
Tax Paid
1.65
1.15
1.39
0.85
2.89
0.19
0.63
1.15
1.42
1.64
-0.03
1.62
Profit After Tax
4.89
3.42
3.72
2.53
8.6
0.58
1.65
3.33
4.13
4.8
0.85
4.71
Total Net profit including share of profit / Loss from associate company
4.89
3.42
3.72
2.53
8.6
0.58
1.65
3.33
4.13
4.8
0.85
4.71
EPS
3.97
2.78
3.02
2.06
6.99
0.47
1.34
2.7
3.36
3.9
0.69
3.83
Actual EPS
3.97
2.78
3.02
2.06
6.99
0.47
1.34
2.7
3.36
3.9
0.69
3.83
Adjusted EPS
3.97
2.78
3.02
2.06
6.99
0.47
1.34
2.7
3.36
3.9
0.69
3.83
Diluted EPS
3.97
2.78
3.02
2.06
6.99
0.47
1.34
2.7
3.36
3.9
0.69
3.83

Par Drugs & Chemicals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
42.38
46.32
55.85
60.75
75.07
95.75
95.64
100.97
103.66
Other Income
0.04
0.09
0.1
2.18
0.18
0.24
0.24
2.15
4
Total Income
42.42
46.41
55.95
62.93
75.26
95.99
95.88
103.12
107.66
Expenses
34.35
38.12
46.4
44.74
58.82
77.54
72.82
81.47
86.52
Operating Profit
8.03
8.2
9.45
16.01
16.25
18.21
22.82
19.5
17.14
Operating Profit Margin %
18.95%
17.7%
16.92%
26.35%
21.65%
19.02%
23.86%
19.31%
16.53%
Profit Before Interest, Tax and Depreciation
8.07
8.29
9.55
18.19
16.44
18.45
23.06
21.65
21.13
Interest
2.33
1.96
0.79
0.64
0.45
0.13
0.11
0.08
0.13
Depreciation
3.14
3.04
2.76
2.82
3.28
3.23
3.44
3.65
3.7
Profit Before Tax
2.6
3.29
6
14.73
12.71
15.09
19.51
17.92
17.3
Tax Paid
1.07
0.78
1.23
3.11
3.49
3.75
5.02
4.57
4.19
Profit After Tax
1.52
2.51
4.77
11.61
9.21
11.33
14.5
13.36
13.11
Total Net profit including share of profit / Loss from associate company
1.52
2.51
4.77
11.61
9.21
11.33
14.5
13.36
13.11
EPS
5.64
5.6
7.75
18.87
7.49
9.21
11.78
10.86
10.65
Actual EPS
5.64
5.6
7.75
18.87
7.49
9.21
11.78
10.86
10.65
Adjusted EPS
2.82
2.8
3.88
9.44
7.49
9.21
11.78
10.86
10.65
Diluted EPS
5.64
5.6
7.75
18.87
7.49
9.21
11.78
10.86
10.65

Par Drugs & Chemicals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
6.53
9.17
4.32
2.1
7.69
12.09
7.62
13.38
20.25
16.16
16.43
Cash Flow from Investing Activities
-0.17
-1.7
-0.6
-0.25
-1.45
0.05
-3.02
-7.33
-5.84
-25.24
-2.17
Cash Flow from Financing Activities
-5.46
-8.38
-3.67
-1.87
1.12
1.65
-9.56
-
-
-
-
Net Cash Flow
0.9
-0.91
0.05
-0.03
7.35
13.78
-4.96
6.04
14.41
-9.08
14.27

Par Drugs & Chemicals Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
74.21%
74.21%
74.21%
73.37%
73.37%
73.37%
73.37%
73.37%
73.41%
73.41%
73.41%
DII
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0.09%
FII
0.07%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Public
25.73%
25.68%
25.47%
26.54%
26.63%
26.63%
26.63%
26.63%
26.59%
26.59%
26.51%
Total Outstanding Shares
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
1,23,04,636
Total Shareholders
7,020
7,403
8,022
8,757
17,199
15,472
14,887
14,280
13,761
13,222
12,782

Par Drugs & Chemicals Corporate Actions

View detailed summary of the earnings and dividend history of Par Drugs & Chemicals.

  • Par Drugs & Chemicals Ltd Earnings Results

    Par Drugs & Chemicals Ltd’s net profit jumped 41.44% since last year same period to ₹4.71Cr in the Q1 2026-2027. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 454.12% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Par Drugs & Chemicals Ltd Dividends November,2021

    In the quarter ending September 2021, Par Drugs & Chemicals Ltd has declared dividend of ₹1.25 per share on 09 Nov 2021 - translating a dividend yield of 0.89%.

    Read More about Dividends

Insights on Par Drugs & Chemicals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, PAR stock has moved up by 36.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 73.41% of holdings in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 167.3% return, outperforming this stock by 191.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 54.7% return, outperforming this stock by 25.0%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 26.59% to 26.51% in Jun 2026 quarter

About Par Drugs & Chemicals Ltd

Par Drugs and Chemicals Limited is an Indian company which is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for both domestic and international markets. It was initially incorporated as a private limited company in Bhavnagar, Gujarat and later converted into a public limited company in October 2018. It has two manufacturing facilities at Bhavnagar and Ankleshwar in Gujarat, comprising of 3 manufacturing blocks for APIs and 2 for Fine Chemicals in Bhavnagar. The company produces a range of popular antacid molecules and markets a total of 12 APIs and 6 Fine Chemicals domestically and for exports to 16 countries. Key customers of the company include Essential Drugs Company Limited, Taurus Chemicals P Limited, Pfizer Limited, United Phosphorus Limited, Samba Jammu Unit and Shiv Silica Private Limited.

Revenue: ₹31.28Cr as on June 2026 (Q1 FY27)
Net Profit: ₹4.71Cr as on June 2026 (Q1 FY27)
Listing date: 16 May, 2019
Chairperson Name: FALGUN VALLABHBHAI SAVANI
OrganisationPar Drugs & Chemicals Ltd
IndustryPharmaceuticals
CEOFALGUN VALLABHBHAI SAVANI
E-voting on sharesClick here to vote

FAQs

What is Par Drugs & Chemicals share price today?

Par Drugs & Chemicals share price today stands at ₹140.92 as on at the close of the market. Par Drugs & Chemicals share today touched a day high of ₹147.96 and a low of ₹134.03.

What is the 52 week high and 52 week low range for Par Drugs & Chemicals share?

Par Drugs & Chemicals touched a 52 week high of ₹180 and a 52 week low of ₹78.05. Par Drugs & Chemicals share price today i.e. is closed at ₹140.92, which is -21.71% down from its 52 week high and 80.55% up from its 52 week low.

What is Par Drugs & Chemicals's market capitalisation today?

Par Drugs & Chemicals market capitalisation is ₹173.40 Cr as on .

How to buy Par Drugs & Chemicals shares?

To buy Par Drugs & Chemicals shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for PAR or Par Drugs & Chemicals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Par Drugs & Chemicals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Par Drugs & Chemicals trading volume today?

Par Drugs & Chemicals trading volume is 76.30K as on . This means that 76.30K shares of Par Drugs & Chemicals were bought and sold on the stock market during today's trading session.